Validation of the prediction score for inhibitor development in previously untreated patients (PUPs) with severe hemophilia A

被引：0
|
作者：
Hashemi, S. [1 ,2 ,3 ]
Fischer, K. [1 ,2 ]
Van den Berg, H. [3 ]
机构：
[1] UMC Utrecht, Dept Creveldklin & Hematol, Utrecht, Netherlands
[2] UMC Utrecht, Julius Ctr Hlth Sci, Utrecht, Netherlands
[3] UMC Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [31] KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS
    LUSHER, J
    ARKIN, S
    ABILDGAARD, CF
    HURST, D
    BLOOD, 1994, 84 (10) : A239 - A239
  • [32] Inhibitor incidence in an unselected cohort of previously untreated patients with severe hemophilia B: a PedNet study
    Male, Christoph
    Andersson, Nadine G.
    Rafowicz, Anne
    Liesner, R. I.
    Kurnik, Karin
    Fischer, Kathelijn
    Platokouki, Helen
    Santagostino, Elena
    Chambost, Herve
    Nolan, Beatrice
    Koeigs, Christoph
    Kenet, Gili
    Ljung, Rolf
    van den Berg, H. Marijke
    HAEMATOLOGICA, 2021, 106 (01) : 123 - 129
  • [33] Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq®, a New Generation Recombinant FVIII of Human Origin
    Liesner, Raina
    Abashidze, Marina
    Aleinikova, Olga
    Altisent, Carmen
    Belletrutti, Mark J.
    Borel-Derlon, Annie
    Carcao, Manuel
    Chambost, Herve
    Chan, Anthony
    Dubey, Leonid
    Ducore, Jonathan M.
    Abubacker, Fouzia Nambiathayil
    Gattens, Michael
    Gruel, Yves
    Kavardakova, Natalya
    Khorassani, Mohamed
    Klukowska, Anna
    Konigs, Christoph
    Lambert, Thierry
    Lohade, Sunil
    Sigaud, Marianne
    Turea, Valentin
    Wu, John K.
    Vdovin, Vladimir
    BLOOD, 2016, 128 (22)
  • [34] Recombinant FVII (Kogenate) treatment of previously untreated patients (PUPs) with hemophilia A: Update of safety, efficacy and inhibitor development after seven study years
    Lusher, J
    Arkin, S
    Abildgaard, CF
    Hurst, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : PD664 - PD664
  • [35] DETERMINING INHIBITOR-DEVELOPMENT RISK IN PREVIOUSLY UNTREATED HEMOPHILIA-A PATIENTS TREATED (PUPS) WITH RECOMBINANT FACTOR-VIII (RECOMBINATE(TM))
    LEE, ML
    COURTER, S
    GOMPERTS, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 856 - 856
  • [36] A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial
    Carcao, Manuel
    Schiavulli, Michele
    Kulkarni, Roshni
    Rendo, Pablo
    Foster, Meredith
    Santagostino, Elena
    Casiano, Sandra
    Koenigs, Christoph
    BLOOD ADVANCES, 2024, 8 (06) : 1494 - 1503
  • [37] Risk of Bleeding and Inhibitor Development After Circumcision of Previously Untreated or Minimally Treated Severe Hemophilia A Children
    Elalfy, Mohsen S.
    Elbarbary, Nancy S.
    Eldebeiky, Mohamed S.
    El Danasoury, Azza S.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2012, 29 (05) : 485 - 493
  • [38] Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A (vol 14, pg 1330, 2016)
    Mannucci, P. M.
    Mancuso, M. E.
    Franchini, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (11) : 2320 - 2320
  • [39] Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
    Masashi Taki
    Katsuyuki Fukutake
    Tadashi Matsushita
    Keiji Nogami
    Midori Shima
    Akira Yoshioka
    Junki Takamatsu
    Morio Arai
    Hiroshi Takagi
    Haruhiko Uchikawa
    Werner Engl
    Akira Shirahata
    International Journal of Hematology, 2019, 109 : 70 - 78
  • [40] Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
    Taki, Masashi
    Fukutake, Katsuyuki
    Matsushita, Tadashi
    Nogami, Keiji
    Shima, Midori
    Yoshioka, Akira
    Takamatsu, Junki
    Arai, Morio
    Takagi, Hiroshi
    Uchikawa, Haruhiko
    Engl, Werner
    Shirahata, Akira
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 70 - 78
12345